Evolution of Clinical Trials- What’s Next?
20 Apr 2021
10:00 am - 11:30 am
Join leading experts to understand how tech has helped clinical trials evolve during Covid-19 and what the future holds for the industry
The challenges brought on by the Covid-19 pandemic have forced the Life sciences industry to come up with innovative solutions and processes to help speed up the delivery of safe and effective medicines. Technology has played a key role in this transformation, from solutions like eConsent and ePRO to Remote Clinical Trials and Patient Engagement Platforms becoming more widely used and acceptable to Regulatory Authorities, Pharma and Patients.
With the approval of vaccines across the world and a return to normalcy in sight, the question facing the research community is which tools to continue and which not to, depending upon regulatory requirements, patient safety, study compliance and data quality.
Discussion point 1: How have clinical trials evolved. A look at how organisations are approaching these as well as a look at the available technologies and promise of remote clinical trials
Discussion point 2: Opportunities in implementing AI/ML in Clinical Trials to improve patient recruitment, better study outcomes, improve data quality and drive down costs
Discussion point 3: A look at how regulators have responded to the challenges and supported the changes.